Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd.

SZSE:300501.SZ

14.24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 288.938256.273257.808230.205267.675260.138298.605233.861248.264231.871235.54192.346205.097223.875220.096167.351170.784155.553163.959152.774140.801163.496150.859116.67129.842109.824106.989.83998.14580.73495.99262.4980.14762.64778.98760.35887.6866.953
Cost of Revenue 204.842183.952179.848160.819188.634186.678217.779175.504177.619170.032166.287140.873149.774152.878141.684111.808107.868108.615115.444104.20595.122112.752102.62982.09983.8272.94464.82759.65660.09550.55862.34737.57246.538.30150.64938.30854.64842.325
Gross Profit 84.09672.32177.9669.38579.04173.4680.82658.35770.64561.83969.25351.47355.32370.99778.41255.54462.91646.93848.51548.5745.67950.74448.2334.5746.02236.8842.07330.18338.0530.17633.64524.91733.64724.34628.33822.0533.03224.628
Gross Profit Ratio 0.2910.2820.3020.3010.2950.2820.2710.250.2850.2670.2940.2680.270.3170.3560.3320.3680.3020.2960.3180.3240.310.320.2960.3540.3360.3940.3360.3880.3740.3510.3990.420.3890.3590.3650.3770.368
Reseach & Development Expenses 12.7768.32715.44510.15715.5618.45613.6017.60215.5547.73312.0715.4499.2196.1399.1073.6796.6934.8169.1743.26610.4593.5384.2271.96117.154021.8194.2740.168016.36206.846016.77808.5120
General & Administrative Expenses -8.69717.266-32.99141.059-6.70613.183-24.2333.033-6.52912.612-29.11332.994-4.91113.954-20.27613.22-5.58313.075-17.55515.756-2.69316.007-8.967.969-5.55612.508-17.49710.779-3.68910.432-14.9947.103-3.8145.883-16.0126.9186.8267.441
Selling & Marketing Expenses 14.04110.44617.8911.11513.44612.27911.2189.2213.92611.24416.4237.7196.43311.98718.41410.58711.01310.9489.7999.1219.6710.05512.4888.0646.1045.1237.5134.5996.1413.654.9012.5834.1792.773.5112.7853.5433.206
SG&A 32.58428.87140.39652.1756.7425.462-13.01242.2537.39723.856-12.6940.7131.52225.94-1.86323.8075.4324.024-7.75724.8776.97626.0623.52816.0330.54817.632-9.98415.3782.45214.082-10.0939.6850.3658.653-12.5019.70310.36810.647
Other Expenses 0.3120.352-10.892-0.19-0.1440.0730.268-0.140.0380.0750.034-0.269-0.068-0.048-0.639-0.091-0.0360.066-6.458-0.226-0.0070.031-1.2370.374-0.2290.223-1.8770.2861.0831.424-0.0480.7320.1690.0811.571-1.2610.2991.517
Operating Expenses 45.04836.84566.73438.39946.38332.74447.23429.23142.46730.16345.64829.15228.10533.12843.08827.72527.86229.26332.28829.07628.23231.15529.39918.94524.54618.15520.10815.92815.81614.51716.8499.7612.1939.04612.5689.93610.76510.782
Operating Income 39.04935.47611.22655.15623.98834.3324.44631.99134.72231.52425.68722.5429.5939.96932.98430.89238.8516.71918.83523.15917.49720.29617.81516.35725.23518.47521.6214.44723.17116.71920.74615.95920.95115.33116.0714.2122.03214.055
Operating Income Ratio 0.1350.1380.0440.240.090.1320.0820.1370.140.1360.1090.1170.1440.1790.150.1850.2270.1070.1150.1520.1240.1240.1180.140.1940.1680.2020.1610.2360.2070.2160.2550.2610.2450.2030.2350.2510.21
Total Other Income Expenses Net -0.435-4.354-0.999-0.19-0.1440.0730.268-0.140.0380.0750.034-0.269-0.068-0.048-0.639-0.091-0.0360.066-6.458-0.226-0.0070.031-1.2370.374-0.2290.223-1.8770.2861.0821.424-0.10.7320.1630.0811.569-1.2610.2981.517
Income Before Tax 38.61431.12210.22754.96623.84434.40324.71431.8534.76131.59825.72122.27129.52139.9232.34530.80138.81416.78512.37822.93317.4920.32616.57816.73125.00618.69819.74314.73324.25318.14220.64616.69121.11415.41217.63812.94922.3315.572
Income Before Tax Ratio 0.1340.1210.040.2390.0890.1320.0830.1360.140.1360.1090.1160.1440.1780.1470.1840.2270.1080.0750.150.1240.1240.110.1430.1930.170.1850.1640.2470.2250.2150.2670.2630.2460.2230.2150.2550.233
Income Tax Expense 6.1866.211-0.2675.385.134.3983.1112.2643.1484.548-1.7111.0913.3215.7031.5634.4315.0732.251-1.2833.1771.9913.5073.3382.8573.3813.0611.351.9264.6313.2643.3062.51.1491.9383.0211.6362.7242.325
Net Income 34.84123.019-5.59648.11916.23326.68619.18628.25429.53825.48325.66320.36325.03333.58730.39525.37232.7914.34714.99819.57214.96417.44214.35614.56821.43815.81618.52912.78519.62514.87316.97414.19119.96513.47314.60611.31319.61213.236
Net Income Ratio 0.1210.09-0.0220.2090.0610.1030.0640.1210.1190.110.1090.1060.1220.150.1380.1520.1920.0920.0910.1280.1060.1070.0950.1250.1650.1440.1730.1420.20.1840.1770.2270.2490.2150.1850.1870.2240.198
EPS 0.180.12-0.0290.250.0840.140.0990.150.150.130.130.130.160.210.210.160.210.090.110.130.0880.170.0990.140.140.160.120.130.110.120.110.120.160.0880.130.0990.170.12
EPS Diluted 0.180.12-0.0290.250.0840.140.0990.150.150.130.130.130.160.210.210.160.210.090.10.130.0880.170.0990.140.140.160.120.130.110.120.110.120.160.0880.130.0990.170.12
EBITDA 54.62234.74325.52757.13129.83337.03133.57632.73235.83334.40731.87223.8232.21342.1535.75132.55543.39417.67515.48224.83722.82219.58918.65120.04325.45418.72528.03314.25527.04515.65822.92315.15821.45415.322.44212.89523.04114.077
EBITDA Ratio 0.1890.1360.0990.2480.1110.1420.1120.140.1440.1480.1350.1240.1570.1880.1620.1950.2540.1140.0940.1630.1620.120.1240.1720.1960.1710.2620.1590.2760.1940.2390.2430.2680.2440.2840.2140.2630.21